FDA Inspection 673207 — Medtronic Neuromodulation
The FDA completed an inspection of Medtronic Neuromodulation on Jul 20, 2010 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 20, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Postmarket Surv. and Epidemiology
- Location
- Minneapolis, MN (United States)